WO2004091280A3 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions Download PDF

Info

Publication number
WO2004091280A3
WO2004091280A3 PCT/US2004/009644 US2004009644W WO2004091280A3 WO 2004091280 A3 WO2004091280 A3 WO 2004091280A3 US 2004009644 W US2004009644 W US 2004009644W WO 2004091280 A3 WO2004091280 A3 WO 2004091280A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
propylcarbamate
phosphonooxy
sulphonyl
aminophenyl
Prior art date
Application number
PCT/US2004/009644
Other languages
French (fr)
Other versions
WO2004091280A2 (en
Inventor
Amyn Pyarali Sayani
Mehran Maleki
Kwok Yui Chow
Original Assignee
Smithkline Beecham Corp
Amyn Pyarali Sayani
Mehran Maleki
Kwok Yui Chow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Amyn Pyarali Sayani, Mehran Maleki, Kwok Yui Chow filed Critical Smithkline Beecham Corp
Publication of WO2004091280A2 publication Critical patent/WO2004091280A2/en
Publication of WO2004091280A3 publication Critical patent/WO2004091280A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to pharmaceutical liquid compositions of (3S)-tetrahydrofuran-3-yl (1S, 2R)-[[(4-aminophenyl) sulphonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate.
PCT/US2004/009644 2003-04-01 2004-03-30 Pharmaceutical compositions WO2004091280A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45929803P 2003-04-01 2003-04-01
US60/459,298 2003-04-01

Publications (2)

Publication Number Publication Date
WO2004091280A2 WO2004091280A2 (en) 2004-10-28
WO2004091280A3 true WO2004091280A3 (en) 2005-02-17

Family

ID=33098296

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/009644 WO2004091280A2 (en) 2003-04-01 2004-03-30 Pharmaceutical compositions

Country Status (3)

Country Link
CA (1) CA2425031A1 (en)
TW (1) TW200501942A (en)
WO (1) WO2004091280A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
US20030176319A1 (en) * 2001-12-14 2003-09-18 Watanabe Kyoichi A. N4-acylcytosine-1,3- dioxolane nucleosides for treatment of viral infections

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
US20030176319A1 (en) * 2001-12-14 2003-09-18 Watanabe Kyoichi A. N4-acylcytosine-1,3- dioxolane nucleosides for treatment of viral infections

Also Published As

Publication number Publication date
WO2004091280A2 (en) 2004-10-28
CA2425031A1 (en) 2004-10-01
TW200501942A (en) 2005-01-16

Similar Documents

Publication Publication Date Title
YU3401A (en) Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-(((4-aminophenyl) sulphonyl)(isobutyl)amino)-1-benzyl-2-(phosphonooxy) propylcarbamate
WO2008064353A3 (en) 7,8-saturated-4,5-epoxy-morphinanium analogs
MX2007004276A (en) 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity.
UA86591C2 (en) Pyrrolodihydroisoquinolines as pde10 inhibitors, pharmaceutical composition based thereon
WO2005075412A3 (en) Norbornane based cycloaliphatic compounds containing nitrile groups
WO2004099132A3 (en) Process for the preparation of trans-isomers of diphenylazetidinone derivatives
WO2005075467A3 (en) Crystalline forms of zolmitriptan
EP1420787B8 (en) Ophthalmic composition comprising an ascomycin
WO2008047249A3 (en) Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them
WO2006133006A3 (en) 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
MX2007006018A (en) Novel oral pharmaceutical suspension of cefdinir crystal.
WO2004105773A3 (en) Use of s1p
WO2005012271A3 (en) Process for the synthesis of biaryl oxazolidinones
WO2006069154A3 (en) Vitamin d receptor modulators
WO2004091280A3 (en) Pharmaceutical compositions
WO2005045428A3 (en) Methods and compositions for modulating apoptosis
WO2004087652A3 (en) Imidazotriazine compounds
WO2008045391A3 (en) Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
AU5818100A (en) Derivatives of (3s) tetrahydro-3-furanyl (1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzy -2-(phosphonooxy)propylcarbamate
WO2006055663A3 (en) The use of novel antibacterial compounds
WO2005060981A3 (en) Pharmaceutical compositions
WO2007044574A3 (en) Pharmaceutical compositions, methods of preparation thereof, and methods of treatment
WO2005016371A8 (en) IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES
WO2002066048A8 (en) Crystal modification of a cyclic depsipeptide having improved strength
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase